Global Genomic Data Analysis and Interpretation Market

Focus on Products, Genomic Platforms, Applications, End Users, Country Data (15 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030

Published Year: 2021
SKU: BHP1026SA

5000

Online Access for One Person. Permission to Print

A quick peek into the report

Table of Contents

Download this TOC  

Request a Sample

1 Product Definition

1.1    Inclusion and Exclusion

2 Market Scope

2.1    Scope of the Study
2.2    Key Questions Answered in the Report
2.3    Global Genomic Data Analysis and Interpretation Market: Research Methodology

3 Research Methodology

3.1    Primary Data Sources
3.2    Secondary Data Sources
3.3    Market Estimation Model
3.4    Criteria for Company Profiling

4 Market Overview

4.1    Market Definition
4.2    Market Footprint and Growth Potential, $Million, 2019-2030
4.3    COVID-19 Impact on Global Genomic Analysis and Interpretation Market

5 Industry Analysis

5.1    Overview
5.2    Legal Requirements and Framework in U.S.
5.3    Legal Requirements and Framework in Europe
5.4    Legal Requirements and Framework in Asia-Pacific
         5.4.1    China
         5.4.2    Japan

6 Market Dynamics

6.1    Overview
6.2    Iceberg Analysis – Global Genomic Data Analysis and Interpretation Market
6.3    Impact Analysis
6.4    Market Drivers
         6.4.1    Decreasing Cost of Sequencing
         6.4.2    Global Increase in Cancer Prevalence
         6.4.3    Increasing Number of Population Genomics Initiatives
6.5    Market Restraints
         6.5.1    Lack of High Complexity Genomic Testing Centers in High Potential Markets
         6.5.2    Challenges Pertaining to Genomic Data Storage
         6.5.3    Scarcity of Knowledge Dissemination Pertaining to Advanced Diagnostic Capabilities
6.6    Market Opportunities
         6.6.1    Massive Scope for Adoption of Genomic Data Analysis Software in Emerging Nations
         6.6.2    Novel Diagnostic Applications

7 Competitive Landscape

7.1    Product Launch and Upgrades
7.2    Synergistic Activities
7.3    Acquisitions
7.4    Market Share Analysis, by Company, 2018-2019
7.5    Growth Share Analysis
         7.5.1    Growth Share Analysis (by Company)
         7.5.2    Growth Share Analysis (by Application)

8 Global Genomic Data Analysis and Interpretation Market (by Product Type)

8.1    Overview
8.2    Software
8.3    Services
         8.3.1    Licenses
         8.3.2    Maintenance

9 Global Genomic Data Analysis and Interpretation Market (by Genomic Platform)

9.1    Overview
9.2    Next-Generation Sequencing (NGS)
9.3    Polymerase Chain Reaction (PCR)
9.4    Microarray
9.5    Other Genomic Platforms

10 Global Genomic Data Analysis and Interpretation Market (by Application)

10.1    Overview
10.2    Research Applications
           10.2.1    Omics-Data Analysis
                         10.2.1.1    Transcriptomics
                         10.2.1.2    Microbiomics
                         10.2.1.3    Proteomics
                         10.2.1.4    Other Omics-Data Analysis
           10.2.2    Population Genomics
           10.2.3    Annotation and Gene Expression
           10.2.4    Other Research Applications
10.3    Clinical Applications
           10.3.1    Oncology
           10.3.2    Rare Diseases
           10.3.3    Infectious Diseases
           10.3.4    Sexual and Reproductive Health
           10.3.5    Other Clinical Applications

11 Global Genomic Data Analysis and Interpretation Market (by End User)

11.1    Overview
11.2    Research and Academic Institutions
11.3    Biotechnology and Biopharmaceutical Companies
11.4    Hospitals and Diagnostic Laboratories
11.5    Contract Research Organizations
11.6    Forensic Laboratories
11.7    Other End Users

12 Global Genomic Data Analysis and Interpretation Market (by Region)

12.1    Overview
12.2    North America
           12.2.1    U.S.
           12.2.2    Canada
           12.2.3    North America Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
12.3    Europe
           12.3.1    Germany
           12.3.2    U.K.
           12.3.3    France
           12.3.4    Italy
           12.3.5    Spain
           12.3.6    Netherlands
           12.3.7    Rest-of-Europe
           12.3.8    Europe Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
12.4    Asia-Pacific
           12.4.1    China
           12.4.2    Japan
           12.4.3    India
           12.4.4    Australia
           12.4.5    South Korea
           12.4.6    Rest-of-Asia-Pacific
           12.4.7    Asia-Pacific Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
12.5    Latin America
           12.5.1    Brazil
           12.5.2    Mexico
           12.5.3    Rest-of-Latin-America
           12.5.4    Latin America Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
12.6    Rest-of-the-World

13 Company Profiles

13.1    Overview
13.2    10x Genomics, Inc.
           13.2.1    Company Overview
           13.2.2    Role of 10x Genomics, Inc. in the Global Genomic Data Analysis and Interpretation Market
           13.2.3    Financials
           13.2.4    Key Insights About Financial Health of the Company
           13.2.5    SWOT Analysis
13.3    Agilent Technologies, Inc.
           13.3.1    Company Overview
           13.3.2    Role of Agilent Technologies, Inc. in the Global Genomic Data Analysis and Interpretation Market
           13.3.3    Financials
           13.3.4    Key Insights About Financial Health of the Company
           13.3.5    SWOT Analysis
13.4    ASURAGEN, INC.
           13.4.1    Company Overview
           13.4.2    Role of ASURAGEN, INC. in the Global Genomic Data Analysis and Interpretation Market
           13.4.3    SWOT Analysis
13.5    Beijing Genomics Institute (BGI) Genomics Co., Ltd
           13.5.1    Company Overview
           13.5.2    Role of Beijing Genomics Institute (BGI) Genomics Co., Ltd in the Global Genomic Data Analysis and Interpretation Market
           13.5.3    SWOT Analysis
13.6    Bio-Rad Laboratories, Inc.
           13.6.1    Company Overview
           13.6.2    Role of Bio-Rad Laboratories, Inc. in the Global Genomic Data Analysis and Interpretation Market
           13.6.3    Financials
           13.6.4    Key Insights About Financial Health of the Company
           13.6.5    SWOT Analysis
13.7    DNASTAR
           13.7.1    Company Overview
           13.7.2    Roles of DNASTAR in the Global Genomic Data Analysis and Interpretation Market
           13.7.3    SWOT Analysis
13.8    F. Hoffmann-La Roche Ltd
           13.8.1    Company Overview
           13.8.2    Role of F. Hoffmann-La Roche Ltd. in the Global Genomic Data Analysis and Interpretation Market
           13.8.3    Financials
           13.8.4    Key Insights About Financial Health of the Company
           13.8.5    SWOT Analysis
13.9    Golden Helix, Inc.
           13.9.1    Company Overview
           13.9.2    Role of Golden Helix, Inc. in the Global Genomic Data Analysis and Interpretation Market
           13.9.3    SWOT Analysis
13.10    Illumina, Inc.
             13.10.1    Company Overview
             13.10.2    Role of Illumina, Inc. in the Global Genomic Data Analysis and Interpretation Market
             13.10.3    Financials
             13.10.4    Key Insights About Financial Health of the Company
             13.10.5    SWOT Analysis
13.11    Oxford Nanopore Technologies, Inc.
             13.11.1    Company Overview
             13.11.2    Role of Oxford Nanopore Technologies, Inc. in the Global Genomic Data Analysis and Interpretation Market
             13.11.3    SWOT Analysis
13.12    Pacific Biosciences of California, Inc.
             13.12.1    Company Overview
             13.12.2    Role of Pacific Biosciences of California, Inc. in the Global Genomic Data Analysis and Interpretation Market
             13.12.3    Financials
             13.12.4    Key Insights About Financial Health of the Company
             13.12.5    SWOT Analysis
13.13    Partek Inc.
             13.13.1    Company Overview
             13.13.2    Role of Partek Inc. in the Global Genomic Data Analysis and Interpretation Market
             13.13.3    SWOT Analysis
13.14    QIAGEN N.V
             13.14.1    Company Overview
             13.14.2    Role of QIAGEN N.V. in the Global Genomic Data Analysis and Interpretation Market
             13.14.3    Financials
             13.14.4    Key Insights About Financial Health of the Company
             13.14.5    SWOT Analysis
13.15    SoftGenetics, LLC.
             13.15.1    Company Overview
             13.15.2    Role of SoftGenetics, LLC in the Global Genomic Data Analysis and Interpretation Market
             13.15.3    SWOT Analysis
13.16    Thermo Fisher Scientific Inc.
             13.16.1    Company Overview
             13.16.2    Role of Thermo Fisher Scientific Inc. in the Global Genomic Data Analysis and Interpretation Market
             13.16.3    Financials
             13.16.4    Key Insights About Financial Health of the Company
             13.16.5    SWOT Analysis

List of Tables

Table 6.1:    Likert Scale
Table 6.2:    Impact Analysis of Market Drivers
Table 6.3:    Impact Analysis of Market Restraints
Table 8.1:    Examples of Software in the Global Genomic Data Analysis and Interpretation Market

List of Figures

Figure 1:    Annual NIH Funding in Human Genomics Research, FY2013-FY2018
Figure 2:    Impact Analysis of Market Drivers and Market Challenges on Global Genomic Data Analysis and Interpretation Market
Figure 3:    Global Genomic Data Analysis and Interpretation Market (by Product), $Million, 2019 vs. 2030
Figure 4:    Global Genomic Data Analysis and Interpretation Market (by Genomic Platform), $Million, 2019 vs. 2030
Figure 5:    Global Genomic Data Analysis and Interpretation Market (by Application), $Million, 2019 vs. 2030
Figure 6:    Global Genomic Data Analysis and Interpretation Market (by End User), $Million, 2019 vs. 2030
Figure 7:    Global Genomic Data Analysis and Interpretation Market Snapshot
Figure 2.1:    Global Genomics Data Analysis and Interpretation, Market Segmentation
Figure 2.2:    Global Genomic Data Analysis and Interpretation Market: Methodology
Figure 3.1:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.2:    Top-Down Approach (Segment-Wise Analysis)
Figure 4.1:    Global Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 4.2:    Global Genomic Data Analysis and Interpretation Market: COVID-19 Impact
Figure 6.1:    Iceberg Analysis – Global Genomic Data Analysis and Interpretation Market
Figure 6.2:    Decreasing Cost and Increasing Output (TB) of Genome Sequencing, 2009-2025
Figure 6.3:    Global Cancer Burden, 2018
Figure 7.1:    Share of Key Developments and Strategies, January 2017-November 2020
Figure 7.2:    Share of Product Launch and Upgrades (by Company), January 2017–November 2020
Figure 7.3:    Share of Synergistic Activities (by Company), January 2017- November 2020
Figure 7.4:    Share of Acquisitions (by Company), January 2017-November 2020
Figure 7.5:    Market Share Analysis for Global Genomic Data Analysis and Interpretation Market, 2018 and 2019
Figure 7.6:    Growth Share Analysis for Global Genomic Data Analysis and Interpretation Market (by Company), 2019
Figure 7.7:    Growth Share Analysis for Global Genomic Data Analysis and Interpretation Market (by Application), 2018-2019
Figure 8.1:    Global Genomic Data Analysis and Interpretation Market (by Product Type)
Figure 8.2:    Global Genomic Data Analysis and Interpretation Market (by Product Type), 2019 and 2030
Figure 8.3:    Global Genomic Data Analysis and Interpretation Market (Software), $Million, 2019-2030
Figure 8.4:    Global Genomic Data Analysis and Interpretation Market (by Services), 2019 and 2030
Figure 8.5:    Global Genomic Data Analysis and Interpretation Market (by Services), $Million, 2019-2030
Figure 8.6:    Global Genomic Data Analysis and Interpretation Market (Licenses), $Million, 2019-2030
Figure 8.7:    Global Genomic Data Analysis and Interpretation Market (Maintenance), $Million, 2019-2030
Figure 9.1:    Global Genomic Data Analysis and Interpretation Market (by Genomic Platform)
Figure 9.2:    Global Genomic Data Analysis and Interpretation Market (by Genomic Platform), 2019 and 2030
Figure 9.3:    Primary Data Analysis in NGS
Figure 9.4:    Secondary Data Analysis in NGS
Figure 9.5:    Tertiary Data Analysis in NGS
Figure 9.6:    Global Genomic Data Analysis and Interpretation Market (NGS), $Million, 2019-2030
Figure 9.7:    Global Genomic Data Analysis and Interpretation Market (PCR), $Million, 2019-2030
Figure 9.8:    Global Genomic Data Analysis and Interpretation Market (Microarray), $Million, 2019-2030
Figure 9.9:    Global Genomic Data Analysis and Interpretation Market (Other Genomic Platforms), $Million, 2019-2030
Figure 10.1:    Global Genomic Data Analysis and Interpretation Market (by Application)
Figure 10.2:    Global Genomic Data Analysis and Interpretation Market (by Application), $Million, 2019-2030
Figure 10.3:    Global Genomic Data Analysis and Interpretation Market (by Research Applications), $Million, 2019-2030
Figure 10.4:    Global Genomic Data Analysis and Interpretation Market (by Omics-Data Analysis), $Million, 2019-2030
Figure 10.5:    Global Genomic Data Analysis and Interpretation Market (Transcriptomics), $Million, 2019-2030
Figure 10.6:    Global Genomic Data Analysis and Interpretation Market (Microbiomics), $Million, 2019-2030
Figure 10.7:    Global Genomic Data Analysis and Interpretation Market (Proteomics), $Million, 2019-2030
Figure 10.8:    Global Genomic Data Analysis and Interpretation Market (Other Omics-Data Analysis), $Million, 2019-2030
Figure 10.9:    Global Genomic Data Analysis and Interpretation Market (Population Genomics), $Million, 2019-2030
Figure 10.10:    Global Genomic Data Analysis and Interpretation Market (Annotation and Gene Expression), $Million, 2019-2030
Figure 10.11:    Global Genomic Data Analysis and Interpretation Market (Other Research Applications), $Million, 2019-2030
Figure 10.12:    Global Genomic Data Analysis and Interpretation Market (by Clinical Application), 2019 and 2030
Figure 10.13:    Global Genomic Data Analysis and Interpretation Market (Oncology), $Million, 2019-2030
Figure 10.14:    Global Genomic Data Analysis and Interpretation Market (Rare Diseases), $Million, 2019-2030
Figure 10.15:    Global Genomic Data Analysis and Interpretation Market (Infectious Diseases), $Million, 2019-2030
Figure 10.16:    Global Genomic Data Analysis and Interpretation Market (Sexual and Reproductive Health), $Million, 2019-2030
Figure 10.17:    Global Genomic Data Analysis and Interpretation Market (Other Clinical Applications), $Million, 2019-2030
Figure 11.1:    Global Genomic Data Analysis and Interpretation Market (by End User), $Million, 2019-2030
Figure 11.2:    Global Genomic Data Analysis and Interpretation Market (Research and Academic Institutions), $Million, 2019-2030
Figure 11.3:    Global Genomic Data Analysis and Interpretation Market (Biotechnology and Pharmaceutical Companies), $Million, 2019-2030
Figure 11.4:    Global Genomic Data Analysis and Interpretation Market (Hospitals and Diagnostic Laboratories), $Million, 2019-2030
Figure 11.5:    Global Genomic Data Analysis and Interpretation Market (Contract Research Organizations), $Million, 2019-2030
Figure 11.6:    Global Genomic Data Analysis and Interpretation Market (Forensic Laboratories), $Million, 2019-2030
Figure 11.7:    Global Genomic Data Analysis and Interpretation Market (Other End Users), $Million, 2019-2030   
Figure 12.1:    Global Genomic Data Analysis and Interpretation Market (by Region), $Million, 2019-2030
Figure 12.2:    Global Genomic Data Analysis and Interpretation Market (by Region), 2019-2030
Figure 12.3:    North America Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.4:    North America: Market Dynamics
Figure 12.5:    North America Genomic Data Analysis and Interpretation Market (by Country), $Million, 2019-2030
Figure 12.6:    U.S. Genomic Data Analysis and Interpretation Market, $Million,  2019-2030
Figure 12.7:    Canada Genomic Data Analysis and Interpretation Market, $Million,  2019-2030
Figure 12.8:    North America Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
Figure 12.9:    Europe Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.10:    Europe: Market Dynamics
Figure 12.11:    Europe Genomic Data Analysis and Interpretation Market (by Country), $Million, 2019-2030
Figure 12.12:    Germany Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.13:    U.K. Genomic Data Analysis and Interpretation Market, $Million,  2019-2030
Figure 12.14:    France Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.15:    Italy Genomic Data Analysis and Interpretation Market, $Million,  2019-2030
Figure 12.16:    Spain Genomic Data Analysis and Interpretation Market, $Million,  2019-2030
Figure 12.17:    Netherlands Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.18:    Rest-of-Europe Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.19:    Europe Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
Figure 12.20:    Asia-Pacific Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.21:    APAC: Market Dynamics
Figure 12.22:    APAC Genomic Data Analysis and Interpretation Market (by Country), $Million, 2019-2030
Figure 12.23:    China Genomic Data Analysis and Interpretation Market, $Million,  2019-2030
Figure 12.24:    Japan Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.25:    India Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.26:    Australia Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.27:    South Korea Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.28:    Rest-of-Asia-Pacific Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.29:    Asia-Pacific Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
Figure 12.30:    Latin America Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.31:    Latin America: Market Dynamics
Figure 12.32:    Latin America Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.33:    Brazil Genomic Data Analysis and Interpretation Market, $Million,  2019-2030
Figure 12.34:    Mexico Genomic Data Analysis and Interpretation Market, $Million, 2019-2030
Figure 12.35:    Rest-of-Latin America Genomic Data Analysis and Interpretation Market,  $Million, 2019-2030
Figure 12.36:    Latin America Genomic Data Analysis and Interpretation Market (by Application), 2019-2030
Figure 12.37:    RoW Genomic Data Analysis and Interpretation Market, $Million,  2019-2030
Figure 13.1:    Total Number of Companies Profiled
Figure 13.2:    10x Genomics, Inc.: Overall Product Portfolio
Figure 13.3:    10x Genomics, Inc.: Overall Financials, 2017-2019
Figure 13.4:    10x Genomics, Inc.: Revenue (by Segment), 2017-2019
Figure 13.5:    10x Genomics, Inc.: Revenue (by Region), 2017-2019
Figure 13.6:    10x Genomics, Inc. R&D Expenditure, 2017-2019
Figure 13.7:    10x Genomics, Inc.: SWOT Analysis
Figure 13.8:    Agilent Technologies, Inc.: Overall Product Portfolio
Figure 13.9:    Agilent Technologies, Inc.: Overall Financials, 2017-2019
Figure 13.10:    Agilent Technologies, Inc.: Revenue (by Segment), 2017-2019
Figure 13.11:    Agilent Technologies, Inc.: Revenue (by Region), 2017-2019
Figure 13.12:    Agilent Technologies, Inc. R&D Expenditure, 2017-2019
Figure 13.13:    Agilent Technologies, Inc.: SWOT Analysis
Figure 13.14:    ASURAGEN, INC.: Overall Product Portfolio
Figure 13.15:    ASURAGEN, INC.: SWOT Analysis
Figure 13.16:    Beijing Genomics Institute (BGI) Genomics Co., Ltd: Overall Product Portfolio
Figure 13.17:    Beijing Genomics Institute (BGI) Genomics Co., Ltd.: SWOT Analysis
Figure 13.18:    Bio-Rad Laboratories, Inc.: Overall Product Portfolio
Figure 13.19:    Bio-Rad Laboratories, Inc.: Overall Financials, 2017-2019
Figure 13.20:    Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2017-2019
Figure 13.21:    Bio-Rad Laboratories, Inc.: Revenue (by Region), 2017-2019
Figure 13.22:    Bio-Rad Laboratories, Inc.: R&D Expenditure, 2017-2019
Figure 13.23:    Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 13.24:    DNASTAR: Overall Product Portfolio
Figure 13.25:    DNASTAR: SWOT Analysis
Figure 13.26:    F. Hoffmann-La Roche Ltd.: Overall Product Portfolio
Figure 13.27:    F. Hoffmann-La Roche Ltd.: Overall Financials, 2017-2019
Figure 13.28:    F. Hoffmann-La Roche Ltd.: Revenue (by Segment), 2017-2019
Figure 13.29:    F. Hoffmann-La Roche Ltd.: Revenue (by Diagnostics), 2017-2019
Figure 13.30:    F. Hoffmann-La Roche Ltd.: Revenue (by Region), 2017-2019
Figure 13.31:    F. Hoffmann-La Roche Ltd.: R&D Expenditure, 2017-2019
Figure 13.32:    F. Hoffmann-La Roche Ltd.: SWOT Analysis
Figure 13.33:    Golden Helix, Inc.: Product Portfolio
Figure 13.34:    Golden Helix, Inc.: SWOT Analysis
Figure 13.35:    Illumina, Inc.: Overall Product Portfolio
Figure 13.36:    Illumina, Inc.: Overall Financials, 2017-2019
Figure 13.37:    Illumina, Inc.: Revenue (by Segment), 2017-2019
Figure 13.38:    Illumina, Inc.: Revenue (by Region), 2017-2020
Figure 13.39:    Illumina, Inc.: R&D Expenditure, 2017-2019
Figure 13.40:    Illumina, Inc.: SWOT Analysis
Figure 13.41:    Oxford Nanopore Technologies, Inc.: Product Portfolio
Figure 13.42:    Oxford Nanopore Technologies, Inc.: SWOT Analysis
Figure 13.43:    Pacific Biosciences of California, Inc.: Overall Product Portfolio
Figure 13.44:    Pacific Biosciences of California, Inc.: Overall Financials, 2017-2019
Figure 13.45:    Pacific Biosciences of California, Inc.: Revenue (by Segment),  2017-2019
Figure 13.46:    Pacific Biosciences of California, Inc.: Revenue (by Region), 2017-2019
Figure 13.47:    Pacific Biosciences of California, Inc.: R&D Expenditure, 2017-2019
Figure 13.48:    Pacific Biosciences of California, Inc.: SWOT Analysis
Figure 13.49:    Partek Inc.: Product Portfolio
Figure 13.50:    Partek Inc.: SWOT Analysis
Figure 13.51:    QIAGEN N.V.: Product Portfolio
Figure 13.52:    QIAGEN N.V.: Overall Financials, 2017-2019
Figure 13.53:    QIAGEN N.V.: Revenue (by Segment), 2017-2019
Figure 13.54:    QIAGEN N.V.: Revenue (by Region), 2017-2019
Figure 13.55:    QIAGEN N.V.: R&D Expenditure, 2017-2019
Figure 13.56:    QIAGEN N.V.: SWOT Analysis
Figure 13.57:    SoftGenetics, LLC: Product Portfolio
Figure 13.58:    SoftGenetics, LLC: SWOT Analysis
Figure 13.59:    Thermo Fisher Scientific Inc.: Product Portfolio
Figure 13.60:    Thermo Fisher Scientific Inc.: Overall Financials: 2017-2020
Figure 13.61:    Thermo Fisher Scientific Inc.: Sales (by Segment): 2017-2020
Figure 13.62:    Thermo Fisher Scientific Inc.: Revenue (by Region), 2017-2019
Figure 13.63:    Thermo Fisher Scientific Inc.: R&D Expenditure, 2017-2019
Figure 13.64:    Thermo Fisher Scientific Inc.: SWOT Analysis

FAQ's

Q. What is the estimated growth rate for genomic data analysis and interpretation market in the coming years?

The genomic data analysis and interpretation market is projected to reach $2.10 Billion by 2030 from $738.7 Million in 2019.

Q. What are the possible factors driving the growth of the genomic data analysis and interpretation market?

Decreasing cost of sequencing, global increase in cancer prevalence, and increasing number of population genomics initiative are some of the factors driving the growth of the market.

Q. What are the possible applications of genomic data analysis and interpretation?

The genomic data analysis and interpretation can be used for various purposes including research (omics-data analysis, population sequencing, annotation and gene expression, and other research applications) and clinical (oncology, rare diseases, infectious diseases, sexual and reproductive health, and other clinical applications).

Q. What are the possible factors restraining the growth of the genomic data analysis and interpretation market?

Factors that are responsible for restraining the growth of the market, include lack of high complexity genomic testing centers in high potential markets, challenges pertaining to genomic data storage, and scarcity of knowledge dissemination pertaining to advanced diagnostic capabilities.

Q. Which are the top market players operating in the genomic data analysis and interpretation market?

Some of the major key players operating in the market include 10x Genomics, Inc., Agilent Technologies, Inc., ASURAGEN INC., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Bio-Rad Laboratories, Inc., DNASTAR, F. Hoffmann-La Roche Ltd., Golden Helix, Inc., Illumina, Inc., Oxford Nanopore Technologies, Inc., Pacific Biosciences of California, Inc., Partek Inc., QIAGEN N.V., SoftGenetics LLC, and Thermo Fisher Scientific Inc.

You may also like

Published Year: 2019

Global Next-Generation Sequencing Market: Focus on Products and Services, Applications, Technology,

In 2018, the global next-generation sequencing market was valued at $4.93 billion and is...

 
Published Year: 2018

Global NGS Informatics and Clinical Genomics Market: Focus on Product Types (LIMS, Data Analysis and

As of 2019, the global NGS informatics and clinical genomics market was estimated to be...

 

Global Genomic Data Analysis and Interpretation Market

Focus on Products, Genomic Platforms, Applications, End Users, Country Data (15 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030